These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31722413)

  • 21. Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate.
    Smolen JS; van Vollenhoven RF; Florentinus S; Chen S; Suboticki JL; Kavanaugh A
    Ann Rheum Dis; 2018 Nov; 77(11):1566-1572. PubMed ID: 30076156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.
    Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Yasuda S; Yamanishi Y; Kita Y; Matsubara T; Iwamoto M; Shoji T; Okada T; van der Heijde D; Miyasaka N; Koike T
    Ann Rheum Dis; 2016 Jan; 75(1):75-83. PubMed ID: 26139005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic Resonance Imaging Bone Edema at Enrollment Predicts Rapid Radiographic Progression in Patients with Early RA: Results from the Nagasaki University Early Arthritis Cohort.
    Nakashima Y; Tamai M; Kita J; Michitsuji T; Shimizu T; Fukui S; Umeda M; Nishino A; Suzuki T; Horai Y; Okada A; Nishimura T; Koga T; Kawashiri SY; Iwamoto N; Ichinose K; Hirai Y; Arima K; Yamasaki S; Nakamura H; Origuchi T; Takao S; Uetani M; Aoyagi K; Eguchi K; Kawakami A
    J Rheumatol; 2016 Jul; 43(7):1278-84. PubMed ID: 27134251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rheumatoid arthritis near remission: clinical rather than laboratory inflammation is associated with radiographic progression.
    Aletaha D; Alasti F; Smolen JS
    Ann Rheum Dis; 2011 Nov; 70(11):1975-80. PubMed ID: 21803751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study.
    Emery P; Bingham CO; Burmester GR; Bykerk VP; Furst DE; Mariette X; van der Heijde D; van Vollenhoven R; Arendt C; Mountian I; Purcaru O; Tatla D; VanLunen B; Weinblatt ME
    Ann Rheum Dis; 2017 Jan; 76(1):96-104. PubMed ID: 27165179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies.
    Mustila A; Korpela M; Haapala AM; Kautiainen H; Laasonen L; Möttönen T; Leirisalo-Repo M; Ilonen J; Järvenpää S; Luukkainen R; Hannonen P
    Clin Exp Rheumatol; 2011; 29(3):500-5. PubMed ID: 21640044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors.
    Teitsma XM; Jacobs JWG; Welsing PMJ; de Jong PHP; Hazes JMW; Weel AEAM; Pethö-Schramm A; Borm MEA; van Laar JM; Lafeber FPJG; Bijlsma JWJ
    Ann Rheum Dis; 2018 Sep; 77(9):1261-1267. PubMed ID: 29760159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis.
    de Rotte MCFJ; Pluijm SMF; de Jong PHP; Bulatović Ćalasan M; Wulffraat NM; Weel AEAM; Lindemans J; Hazes JMW; de Jonge R
    PLoS One; 2018; 13(12):e0208534. PubMed ID: 30532219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of radiographic joint damage in rheumatoid arthritis patients in DAS28 remission using single- or combined with methotrexate non biological disease-modifying antirheumatic drug therapy in routine clinical practice.
    Katayama K; Okubo T; Sato T; Ito H; Fukai R; Baba H
    Mod Rheumatol; 2015 Jan; 25(1):50-5. PubMed ID: 24983407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway.
    Nikolaisen C; Kvien TK; Mikkelsen K; Kaufmann C; Rødevand E; Nossent JC
    Scand J Rheumatol; 2009; 38(4):240-5. PubMed ID: 19229766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression.
    Wells AF; Westhovens R; Reed DM; Fanti L; Becker JC; Covucci A; Keystone EC
    J Rheumatol; 2011 Nov; 38(11):2362-8. PubMed ID: 21885491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of clinical response and radiographic progression in patients with rheumatoid arthritis treated with methotrexate monotherapy.
    Drouin J; Haraoui B;
    J Rheumatol; 2010 Jul; 37(7):1405-10. PubMed ID: 20436076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiological progression in early rheumatoid arthritis after DMARDS: a one-year follow-up study in a clinical setting.
    Sanmarti R; Gomez A; Ercilla G; Gratacos J; Larrosa M; Suris X; Vinas O; Salvador G; Munoz-Gomez J; Canete JD
    Rheumatology (Oxford); 2003 Sep; 42(9):1044-9. PubMed ID: 12730518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial.
    Rezaei H; Saevarsdottir S; Forslind K; Albertsson K; Wallin H; Bratt J; Ernestam S; Geborek P; Pettersson IF; van Vollenhoven RF
    Ann Rheum Dis; 2012 Feb; 71(2):186-91. PubMed ID: 21930734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical, functional, and radiographic implications of time to treatment response in patients with early rheumatoid arthritis: a posthoc analysis of the PREMIER study.
    Keystone EC; Haraoui B; Guérette B; Mozaffarian N; Liu S; Kavanaugh A
    J Rheumatol; 2014 Feb; 41(2):235-43. PubMed ID: 24293583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of multi-biomarker disease activity score and other risk factors with radiographic progression in an observational study of patients with rheumatoid arthritis.
    Li W; Sasso EH; van der Helm-van Mil AH; Huizinga TW
    Rheumatology (Oxford); 2016 Feb; 55(2):357-66. PubMed ID: 26385370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-regulated dipeptidyl-peptidase IV (CD26) on monocytes was unaffected by effective DMARD treatment in early steroid and DMARD-naive rheumatoid arthritis.
    Ellingsen T; Hansen I; Thorsen J; Kuno Møller B; Tarp U; Jacobsen S; Lund Hetland M; Vestergaard A; Hørslev-Petersen K; Stengaard-Pedersen K
    Clin Exp Rheumatol; 2012; 30(1):58-63. PubMed ID: 22273590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Very early MRI responses to therapy as a predictor of later radiographic progression in early rheumatoid arthritis.
    Conaghan PG; Østergaard M; Troum O; Bowes MA; Guillard G; Wilkinson B; Xie Z; Andrews J; Stein A; Chapman D; Koenig A
    Arthritis Res Ther; 2019 Oct; 21(1):214. PubMed ID: 31639034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients.
    Humby F; Lewis M; Ramamoorthi N; Hackney JA; Barnes MR; Bombardieri M; Setiadi AF; Kelly S; Bene F; DiCicco M; Riahi S; Rocher V; Ng N; Lazarou I; Hands R; van der Heijde D; Landewé RBM; van der Helm-van Mil A; Cauli A; McInnes I; Buckley CD; Choy EH; Taylor PC; Townsend MJ; Pitzalis C
    Ann Rheum Dis; 2019 Jun; 78(6):761-772. PubMed ID: 30878974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baseline MRI bone erosion predicts the subsequent radiographic progression in early rheumatoid arthritis patients who achieved sustained good clinical response.
    Tamai M; Arima K; Nakashima Y; Kita J; Umeda M; Fukui S; Nishino A; Suzuki T; Horai Y; Okada A; Koga T; Kawashiri SY; Iwamoto N; Ichinose K; Yamasaki S; Nakamura H; Origuchi T; Aoyagi K; Uetani M; Eguchi K; Kawakami A
    Mod Rheumatol; 2017 Nov; 27(6):961-966. PubMed ID: 28269999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.